TNDM - TANDEM DIABETES CARE INC


23.41
-0.330   -1.410%

Share volume: 1,761,968
Last Updated: 03-04-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%

$23.74
-0.33
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
41%
Profitability 25%
Dept financing 50%
Liquidity 40%
Performance 55%
Company vs Stock growth
vs
Performance
5 Days
-7.21%
1 Month
23.60%
3 Months
11.90%
6 Months
86.09%
1 Year
22.50%
2 Year
-13.63%
Key data
Stock price
$23.41
P/E Ratio 
0.00
DAY RANGE
$23.38 - $24.48
EPS 
-$3.04
52 WEEK RANGE
$9.98 - $29.65
52 WEEK CHANGE
$25.05
MARKET CAP 
1.490 B
YIELD 
N/A
SHARES OUTSTANDING 
68.326 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-31-2025
BETA 
1.52
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,858,816
AVERAGE 30 VOLUME 
$2,715,662
Company detail
CEO: John F. Sheridan
Region: US
Website: tandemdiabetes.com
Employees: 2,600
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Tandem Diabetes Care, Inc. designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system. It also offers t:connect, a web-based data management application, continuous glucose monitoring, and supported blood glucose meters.

Recent news